Pharmacovigilance Risk Assessment Committee (PRAC): 14-17 April 2020
EventHumanPharmacovigilance
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
Date
Location
The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.
|
Update: Please note that EMA will publish the outcomes and highlights of this meeting at 15:00 Central European Time (CET) on 17 April 2020.
|